BALA CYNWYD, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

scPharmaceuticals Inc. (Nasdaq – SCPH)

Under the terms of the Merger Agreement, scPharmaceuticals will be acquired by MannKind Corporation (Nasdaq - MNKD) for $5.35 per share in cash at closing plus one non-tradable CVR per share to receive certain milestone payments of up to an aggregate of $1.00 per CVR in cash, for total consideration of up to $6.35 per share in cash. The investigation concerns whether the ScPharmaceuticals Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/scpharmaceuticals-inc-nasdaq-scph/.

Vital Energy, Inc. (NYSE – VTLE)

Under the terms of the Merger Agreement, Vital Energy will be acquired by Crescent Energy Company (NYSE - CRGY) (“Crescent”). Vital shareholders will receive 1.9062 shares of Crescent Class A common stock for each share of Vital common stock, in an all-stock transaction valued at approximately $3.1 billion. The investigation concerns whether the Vital Energy Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company’s shareholders. For example, the deal consideration is below the 52-week high of $37.33 for the Company’s shares.

Additional information can be found at https://www.brodskysmith.com/cases/vital-energy-inc-nyse-vtle/.

International Money Express, Inc. (Nasdaq - IMXI)

Under the terms of the agreement, Intermex will be acquired by The Western Union Company (“Western Union”) (NYSE - WU) for $16.00 per share in cash for each share of common stock they own. The investigation concerns whether the Intermex Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company’s shareholders. For example, the deal consideration is less than the 52-week high of $22.37 for the Company’s shares.

Additional information can be found at https://www.brodskysmith.com/cases/international-money-express-inc-nasdaq-imxi/.

HanesBrands Inc. (NYSE - HBI)

Under the terms of the agreement, HanesBrand will be acquired by Gildan Activewear Inc. (“Gildan”) (NYSE - GIL). HanesBrands shareholders will receive 0.102 common shares of Gildan and $0.80 in cash for each share of HanesBrands common stock. Based on the closing price of Gildan and HanesBrands’ common stock on August 11, 2025, the offer implies a value of $6.00 per HanesBrands share. The investigation concerns whether the HanesBrands Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company’s shareholders. For example, the deal consideration is below the 52-week high of $9.10 for the Company’s shares and upon completion of the deal, HanesBrands shareholders will own approximately 19.9% of the combined company.

Additional information can be found at https://www.brodskysmith.com/cases/hanesbrands-nyse-hbi/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.